UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

8 May 2024

UCB presents final open-label extension FINTEPLA®▼(fenfluramine)[1] data at International Child Neurology Congress (ICNC) Annual Meeting

Read More
3 May 2024

Acquisition of own shares

Read More
26 Apr 2024

Acquisition of own shares

Read More
25 Apr 2024

UCB’s General Meeting of Shareholders 2024

Read More
25 Apr 2024

UCB off to a Good Start into 2024 – Progressing on its Growth Path for a Decade Plus

Read More
23 Apr 2024

Transparency notification FMR LLC

Read More

Stay up-to-date on the latest news and information from UCB